Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Metabolism and Physiological Effects of Creatine
Homo sapiens
Metabolic Pathway
Creatine is a nitrogenous low-molecular-weight water-soluble organic acid mostly stored in muscle. Mammals get creatine from their diet - meat, fish, and supplements contain L-arginine (an essential amino acid), among other amino acids such as glycine and S-adenosyl-L-methionine, which are involved in energy transfer via phosphocreatine. These can be metabolized to creatine before excretion through the kidney. After arginine enters the body, it is absorbed in the intestinal epithelium to the bloodstream and transported to the liver via an amino acid transporter where it undergoes two metabolic reactions. First, arginine is used to form guanidinoacetic acid in a reaction catalysed by glycine amidinotransferase, then that product undergoes a reaction catalysed by guanidinoacetate N-methyltransferase to form creatine. Creatine then exits the hepatocyte and enters the blood via a sodium- and chloride-dependent creatine transporter; here, it can induce systemic oxidative stress and lead to the toxic effect of cell death.
References
Metabolism and Physiological Effects of Creatine References
Popkov, V. A., Silachev, D. N., Zalevsky, A. O., Zorov, D. B., & Plotnikov, E. Y. (2019). Mitochondria as a source and a target for uremic toxins. International journal of molecular sciences, 20(12), 3094.
Wyss, M., & Kaddurah-Daouk, R. (2000). Creatine and creatinine metabolism. Physiological reviews, 80(3), 1107-1213.
Humm, A., Fritsche, E., Steinbacher, S., & Huber, R. (1997). Crystal structure and mechanism of human L‐arginine: glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis. The EMBO journal, 16(12), 3373-3385.
Yavuz, A., Tetta, C., Ersoy, F. F., D’intini, V., Ratanarat, R., De Cal, M., ... & Ronco, C. (2005, May). Reviews: uremic toxins: a new focus on an old subject. In Seminars in dialysis (Vol. 18, No. 3, pp. 203-211). Oxford, UK: Blackwell Science Inc.
Inoue, Y., Bode, B. P., Beck, D. J., Li, A. P., Bland, K. I., & Souba, W. W. (1993). Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors. Annals of surgery, 218(3), 350.
Guimbal, C., & Kilimann, M. W. (1994). A creatine transporter cDNA from Torpedo illustrates structure/function relationships in the GABA/noradrenaline transporter family. Journal of molecular biology, 241(2), 317-324.
Barcelos, R. P., Stefanello, S. T., Mauriz, J. L., Gonzalez-Gallego, J., & Soares, F. A. A. (2016). Creatine and the liver: metabolism and possible interactions. Mini reviews in medicinal chemistry, 16(1), 12-18.
Taegtmeyer H, Ingwall JS: Creatine--a dispensable metabolite? Circ Res. 2013 Mar 15;112(6):878-80. doi: 10.1161/CIRCRESAHA.113.300974.
Pubmed: 23493302
Lisowska-Myjak B: Uremic toxins and their effects on multiple organ systems. Nephron Clin Pract. 2014;128(3-4):303-11. doi: 10.1159/000369817. Epub 2014 Dec 19.
Pubmed: 25531673
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Settings